Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Non Operating Income (2016 - 2021)

Phio Pharmaceuticals' Non Operating Income history spans 10 years, with the latest figure at -$1000.0 for Q4 2021.

  • For Q4 2021, Non Operating Income changed N/A year-over-year to -$1000.0; the TTM value through Dec 2021 reached $224000.0, up 22500.0%, while the annual FY2023 figure was -$2000.0, 88.89% up from the prior year.
  • Non Operating Income reached -$1000.0 in Q4 2021 per PHIO's latest filing, up from -$3000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $231000.0 in Q1 2021 to a low of -$11000.0 in Q4 2017.
  • Average Non Operating Income over 5 years is $19666.7, with a median of -$1000.0 recorded in 2018.
  • Peak YoY movement for Non Operating Income: crashed 173.33% in 2017, then surged 4520.0% in 2021.
  • A 5-year view of Non Operating Income shows it stood at -$11000.0 in 2017, then skyrocketed by 163.64% to $7000.0 in 2018, then rose by 28.57% to $9000.0 in 2019, then crashed by 133.33% to -$3000.0 in 2020, then surged by 66.67% to -$1000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Non Operating Income are -$1000.0 (Q4 2021), -$3000.0 (Q3 2021), and -$3000.0 (Q2 2021).